Epidemiology of sepsis: An update
The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We review the case definition, occurrence, and outcome of sepsis. We discuss whether the epidemiology of sepsis has changed over time and discuss issues important to our understanding of sepsis. DATA SOURCES: Literature review. DATA SUMMARY: Our understanding of the epidemiology of sepsis is hampered by the lack of a reliable case definition. Inconsistent application of sepsis definition criteria contributes to confusion and variability in the literature. Variability in the time course of sepsis also introduces difficulty. The Centers for Disease Control estimated an incidence of 73.6 per 100,000 population in 1979, rising to 175.9 per 100,000 in 1989. However, this study was of septicemia, not severe sepsis. There are several hospital-based studies of the occurrence of severe sepsis, defined using the American College of Chest Physicians/Society of Critical Care Medicine consensus criteria. These studies reported variable hospital and intensive care unit (ICU) occurrence rates, ranging from 2% to 11% of all hospital or ICU admissions. Most of these data are from academic, tertiary care centers, which limits generalizability. More population-based studies are required to better delineate the incidence and risk factors of sepsis in the general population. Hospital mortality from sepsis has ranged from 25% to 80% over the last few decades. Although mortality may be lower in recent years, sepsis is clearly still a very serious condition. Achieving a better understanding of whether the mortality rate for sepsis is falling, however, is confounded by the lack of a uniform definition. Risk factors for adverse outcome include the degree of physiologic derangement, organ dysfunction, underlying illness, site of infection, and microbiological etiology. We do not know, however, the factors that predict response to new therapies. This dilemma has led researchers to explore whether markers of the inflammatory cascade might be more specific for sepsis, more accurate for risk prediction, or more useful for predicting response to therapy. However, there as yet is no equivalent of the CPK-MB for acute myocardial infarction. Whether we will find such a marker as we develop a greater understanding of the genetic control of the inflammatory cascade is uncertain but promising. One might assume intuitively that the epidemiology of sepsis is changing. For example, the number of patients being treated in ICUs has increased over time, the technologies used in the ICU have changed, and the choice and the use of antibiotics have changed. Predisposing factors, such as chemotherapeutic regimens, have also changed, and there have been marked changes in antibiotic resistance. Furthermore, there have been wide changes in the microbiological etiologies of diseases such as pneumonia and acute exacerbations of chronic bronchitis. However, lacking good case definitions and true incidence studies, we can only make inferences about whether the epidemiology of sepsis is truly changing. CONCLUSION: Many studies have documented many aspects of the epidemiology of sepsis. However, the composite picture they provide, although rich in many aspects, remains incomplete and emphasizes the heterogeneity of the condition. Unfortunately, few population-based prospective cohort studies exist that allow us to accurately delineate the risk factors for sepsis, its course, and its outcome. To place new information, such as the role of genetic predisposition, in the correct context, it is essential that such studies be conducted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, the lower sepsis incidence in MIMIC-IV-ED (2.53%) based on Sepsis 3.0 criteria compared to studies using the Argus Sepsis ICD definition32 may have contributed to the variation.”
From Development and validation of a screening tool for sepsis without laboratory results in the emergency department: a machine learning study (2025) · cites this paper as [32]
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
Rangel-Frausto, M. S. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,104 · cited 2×
“(8) also noted this stepwise progression in mortality based on severity (7% mortality from SIRS, 16% mortality from sepsis, 20% mortality from severe sepsis, and 46% mortality from septic shock).”
BackgroundPlasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome
Casey, L. C., Balk, R. A., & Bone, R. C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-8-199310150-00001 · Cited by 1,041
Serum Cytokine Levels in Human Septic Shock
Pinsky, M. R., Vincent, J.-L., Deviere, J., Alegre, M., Kahn, R. J., & Dupont, E. (1993) · Chest · doi:10.1378/chest.103.2.565 · Cited by 884
Brun-Buisson, C. (1995) · JAMA · doi:10.1001/jama.1995.03530120060042 · Cited by 772
Mira, J.-P., Cariou, A., Grall, F., Delclaux, C., Losser, M.-R., Heshmati, F., Cheval, C., Monchi, M., Teboul, J.-L., Riché, F., et al. (1999) · JAMA · doi:10.1001/jama.282.6.561 · Cited by 740 · cited 2×
“(36) TNF1/2 Incidence and severity (mortality) Case-control Caucasian, healthy blood donors Septic shock 89 cases, 87 controls”
BackgroundEpidemiology of Sepsis Syndrome in 8 Academic Medical Centers
Sands, K. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550030074038 · Cited by 663
Has the mortality of septic shock changed with time?
Friedman, G., Silva, E., & Vincent, J.-L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199812000-00045 · Cited by 607 · cited 4×
“Reproduced with permission from Friedman et al (13).”
BackgroundMethodInfluentialStuber, F., Petersen, M., Bokelmann, F., & Schade, U. (1996) · Critical Care Medicine · doi:10.1097/00003246-199603000-00004 · Cited by 551 · cited 1×
“(32) LT-a (TNFB1/2) Severity (mortality) Cohort, cases of severe sepsis 40 patients with severe sepsis, mixed etiology Schroeder et al.”
BackgroundEFFECT OF GENDER AND SEX HORMONES ON IMMUNE RESPONSES FOLLOWING SHOCK
Angele, M. K., Schwacha, M. G., Ayala, A., & Chaudry, I. H. (2000) · Shock · doi:10.1097/00024382-200014020-00001 · Cited by 528 · cited 1×
“to hemorrhagic shock (39), including responses to immunomodulation therapy (40), were noted.”
Background
Research works printed but not linked: 6
- Kieft, 1993, Arch Intern Med, 153, 2241, 10.1001/archinte.1993.00410190081010 · doi:10.1001/archinte.1993.00410190081010
- 1990, MMWR Morb Mortal Wkly Rep, 39, 31
- Rangel-Frausto, 1995, JAMA, 273, 117, 10.1001/jama.1995.03520260039030 · DOI · Paper page
- Angus, 1996, Intensive Care Med, 22, 273
- Knaus, 1993, JAMA, 270, 1233, 10.1001/jama.1993.03510100083038 · doi:10.1001/jama.1993.03510100083038
- Stuber, 1995, J Inflamm, 46, 42
Cited by
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
Self-citationFleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548
Self-citationHMGB1 and RAGE in Inflammation and Cancer
Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132603 · Cited by 1,436
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
Bhatia, M., & Moochhala, S. (2004) · The Journal of Pathology · doi:10.1002/path.1491 · Cited by 1,095
Metadata
- Authors
- Angus, D. C., & Wax, R. S.
- Affiliations
- University of Pittsburgh (US)
- Mount Sinai Hospital (CA)
- Venue
- Critical Care Medicine
- Published
- 2001-07
- Volume
- 29
- Issue
- 7 Suppl
- Pages
- S109-S116
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2037533969
- Cited by
- 813
- References
- 49
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 10 · 2023: 6 · 2022: 4 · 2021: 13 · 2020: 16 · 2019: 26 · 2018: 20 · 2017: 33 · 2016: 37 · 2015: 37 · 2014: 57 · 2013: 58 · 2012: 53
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Keywords
- sepsis, sepsis epidemiology, sepsis incidence, sepsis mortality, severe sepsis, septic shock, risk factors, inflammatory markers, organ dysfunction, sepsis outcome prediction, intensive care unit admission, antibiotic use, septicemia
- MeSH terms
- Centers for Disease Control and Prevention, U.S., Critical Care, Humans, Inflammation, Intensive Care Units, Patient Admission, Polymorphism, Genetic, Population Surveillance, Predictive Value of Tests, Risk Factors, Severity of Illness Index, Time Factors, United States, Epidemiologic Research Design, Incidence, Treatment Outcome, Hospital Mortality, Sepsis, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiology of sepsis: An update. https://app.cochat.ai/papers/10.1097/00003246-200107001-00035
- The paper
- Angus, D. C., & Wax, R. S. (2001). Epidemiology of sepsis: An update. Critical Care Medicine. https://doi.org/10.1097/00003246-200107001-00035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.